View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
FCC RIN: 3060-AJ25 Publication ID: Fall 2014 
Title: Additional Spectrum for the Medical Device Radiocommunication Service (ET Docket No. 09-36) 
Abstract: In the Notice of Proposed Rulemaking (NPRM), the Commission seeks comment on the feasibility of allowing up to 24 megahertz of spectrum in the 413-457 MHz band to be used on a secondary basis under the umbrella of the existing Medical Device Radiocommunication Service. This action reflects the Commission's ongoing effort to foster the development and deployment of advanced medical devices using wireless technologies that benefit the health and well-being of the American public. In the Report and Order (R&O), the Commission expands the Medical Device Radiocommunication (MedRadio) Service under part 95 of the Commission's rules to permit the use of new wideband medical implant devices that employ neuromuscular microstimulation techniques to restore sensation, mobility, and other functions to paralyzed limbs and organs. These medical devices hold enormous promise to advance the state of medical care, lower health costs, and improve the quality of life for countless Americans. The rules adopted by the Commission will allow these new types of MedRadio devices to access 24 megahertz of spectrum in the 413-419 MHz, 426-432 MHz, 438-444 MHz, and 451-457 MHz bands on a secondary basis. The Commission's action is part of a larger effort to recognize and facilitate the significant advances in wireless medical technologies that are revolutionizing treatment for a wide variety of medical conditions and creating new health care models to benefit all Americans. Such advances have the potential to significantly improve the quality of life and sophistication of therapy for countless Americans living with a variety of medical conditions and, in turn, could result in lower medical costs and extend the time between hospital visits and surgical procedures. The devices that we expect to be deployed under the rules we adopt herein hold the promise of safer, less invasive, and more effective treatment options than those available under current medical practice. 
Agency: Federal Communications Commission(FCC)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 47 CFR 2    47 CFR 95   
Legal Authority: 47 USC 154(i)    47 USC 301 and 302    47 USC 303(e) and 303(f)    47 USC 303(r)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  05/13/2009  74 FR 22491   
NPRM Comment Period End  08/08/2009    
R&O  01/27/2012  77 FR 4252   
Next Action Undetermined  To Be Determined    
Additional Information: ET Docket No. 09-36
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Gary Thayer
Electronics Engineer
Federal Communications Commission
445 12th Street SW.,
Washington, DC 20554
Phone:202 418-2290
Email: gary.thayer@fcc.gov